أعرض في EDS

Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis and F508del/F508del-CFTR: patient-reported outcomes in a Phase 3, randomised, controlled trial (EVOLVE)

التفاصيل البيبلوغرافية
العنوان: Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis and F508del/F508del-CFTR: patient-reported outcomes in a Phase 3, randomised, controlled trial (EVOLVE)
المؤلفون: JS Elborn, O Sommerburg, X You, Y Yang, R Rendas-Baum, M Kosinski, B Loop, J Lekstrom-Himes, AA Rizio
المصدر: 60. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V..
بيانات النشر: Georg Thieme Verlag KG, 2019.
سنة النشر: 2019
مصطلحات موضوعية: medicine.medical_specialty, business.industry, medicine.disease, Cystic fibrosis, law.invention, Ivacaftor, Randomized controlled trial, law, Internal medicine, medicine, Tezacaftor, F508del cftr, In patient, business, medicine.drug
تدمد: 1438-8790
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::15df56e028ae97884c59a2c565588bc2
https://doi.org/10.1055/s-0039-1678165
رقم الأكسشن: edsair.doi...........15df56e028ae97884c59a2c565588bc2
قاعدة البيانات: OpenAIRE
الوصف
تدمد:14388790